{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:25Z","timestamp":1792790485985,"version":"4.5.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>\n                      Phyllodes tumors are uncommon fibroepithelial breast neoplasms with variable biologic behavior. Synchronous bilateral phyllodes tumors are exceptionally rare, and the interpretation of\n                      <jats:sup>18<\/jats:sup>\n                      F-fluorodeoxyglucose positron emission tomography\/computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET-CT) may be confounded by tumor necrosis and inflammation, leading to false-positive nodal staging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns<\/jats:title>\n                    <jats:p>A 44-year-old Korean woman presented with a rapidly enlarging, painful, ulcerated left breast mass for 3 months. She had no nipple discharge, fever, or weight loss. A right breast lesion was clinically occult.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses<\/jats:title>\n                    <jats:p>\n                      Ultrasound showed a right breast hypoechoic nodule (BI-RADS 4A) with scant vascularity and an elastography score of 2, and a giant heterogeneous hypervascular left breast mass with enlarged axillary lymph nodes and an elastography score of 4.\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET-CT revealed intense uptake in the left breast mass (SUV\n                      <jats:sub>max<\/jats:sub>\n                      11.5) and markedly FDG-avid ipsilateral axillary nodes (SUV\n                      <jats:sub>max<\/jats:sub>\n                      9.0), suspicious for metastasis; mild uptake was seen in the right breast nodule (SUV\n                      <jats:sub>max<\/jats:sub>\n                      1.7) without definite distant metastasis. Core needle biopsy supported a fibroepithelial neoplasm favoring phyllodes tumor. Final pathology confirmed a left borderline phyllodes tumor and a right benign phyllodes tumor; all 21 axillary lymph nodes showed reactive hyperplasia with sinus histiocytosis and no metastasis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>After multidisciplinary review, the patient underwent excision of the right breast mass with frozen-section margin assessment, left total mastectomy including the nipple-areola complex and ulcerated skin to achieve negative margins, and level I-II axillary lymph node dissection because sentinel lymph node biopsy was considered unreliable in the setting of massive ulceration and severe axillary edema.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Recovery was uneventful. Ceftriaxone sodium 2.0\u00a0g was given intravenously once daily from 1 day before surgery through postoperative day 5. No wound infection, seroma, fever, or unexpected adverse events occurred. At 1 month, CA125, CA15-3, and CA19\u20139 had normalized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons<\/jats:title>\n                    <jats:p>In phyllodes tumors, marked axillary FDG avidity may reflect reactive inflammation rather than true nodal metastasis, particularly in giant ulcerated tumors with necrosis. Management should emphasize complete excision with negative margins and cautious axillary surgery guided by clinicopathologic correlation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1825190","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:47Z","timestamp":1776658427000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Synchronous bilateral phyllodes tumors with discordant grades and false-positive axillary 18F-FDG PET-CT uptake: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Tianle","family":"Yu","sequence":"first","affiliation":[{"name":"The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyong","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Cai","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2025.100617","article-title":"Phyllodes tumors of the breast: a comprehensive review of diagnosis, treatment, and follow-up","volume":"80","author":"Donato","year":"2025","journal-title":"Clinics (Sao Paulo)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-07134-5","article-title":"Local recurrence of benign, borderline, and malignant phyllodes tumors of the breast: a systematic review and meta-analysis","volume":"26","author":"Lu","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4021\/wjon2010.01.1204","article-title":"Synchronous bilateral benign phyllodes tumor of the breast in a 32-year-old woman","volume":"1","author":"Trabelsi","year":"2010","journal-title":"World J Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/gs-21-789","article-title":"Surgical management in phyllodes tumors of the breast: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2022","journal-title":"Gland Surg"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54464","article-title":"Accuracy and comparison of core needle biopsy diagnoses with excision specimen for diagnosing fibroepithelial lesions of the breast","volume":"16","author":"Tariq","year":"2024","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.14148","article-title":"18F-FDG PET\/CT findings in a giant Malignant phyllodes breast tumor","volume":"27","author":"Wang","year":"2021","journal-title":"Breast J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4048\/jbc.2024.0284","article-title":"Recent advances in Malignant phyllodes tumors of the breast","volume":"28","author":"Lee","year":"2025","journal-title":"J Breast Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08510-8","article-title":"MRI-based radiomics analysis for differentiating phyllodes tumors of the breast from fibroadenomas","volume":"32","author":"Tsuchiya","year":"2022","journal-title":"Eur Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-3402487","article-title":"Immunohistochemical expression of Ki-67, p53, and CD10 in phyllodes tumor and their correlation with its histological grade","volume":"11","author":"Shubham","year":"2019","journal-title":"J Lab Physicians"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2021.03.013","article-title":"Phyllodes tumors of the breast: adjuvant radiation therapy revisited","volume":"58","author":"Boutrus","year":"2021","journal-title":"Breast"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08217-y","article-title":"Surgical margins and adjuvant therapies in malignant phyllodes tumors of the breast: a multicenter retrospective study","volume":"27","author":"Neron","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13473","article-title":"Local recurrence for phyllodes tumours of the breast: systematic review and meta-analysis","volume":"24","author":"Boutas","year":"2022","journal-title":"Oncol Lett"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5585-5","article-title":"Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis","volume":"19","author":"Chao","year":"2019","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4838-3","article-title":"Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08)","volume":"171","author":"Choi","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106969","article-title":"Management of phyllodes tumor: a systematic review and meta-analysis of real-world evidence","volume":"107","author":"Yu","year":"2022","journal-title":"Int J Surg"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2020.02.048","article-title":"Phyllodes tumours of the breast: outcomes and recurrence after excision","volume":"219","author":"Wen","year":"2020","journal-title":"Am J Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07210-4","article-title":"Long-term outcomes after surgical treatment of malignant\/borderline phyllodes tumors of the breast","volume":"26","author":"Spanheimer","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/reports8010017","article-title":"Phyllodes tumor of the breast: a case report regarding the importance of fast interdisciplinary management","volume":"8","author":"Liscu","year":"2025","journal-title":"Reports"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v6.i12.890","article-title":"Postoperative reactive lymphadenitis: a potential cause of false-positive FDG PET\/CT","volume":"6","author":"Liu","year":"2014","journal-title":"World J Radiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2022.0061","article-title":"18F-FDG and 18F-FLT Uptake Profiles for Breast Cancer Cell Lines Treated with Targeted PI3K\/Akt\/mTOR Therapies","volume":"38","author":"Dockx","year":"2023","journal-title":"Cancer Biother Radiopharm"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v8.i11.880","article-title":"Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer","volume":"8","author":"Kawada","year":"2016","journal-title":"World J Radiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109168","article-title":"The impact of infection and inflammation in oncologic 18F-FDG PET\/CT imaging","volume":"117","author":"Rahman","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1358070","article-title":"Applications of FAPI PET\/CT in the diagnosis and treatment of breast and the most common gynecologic Malignancies: a literature review","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ph17060716","article-title":"The role of fibroblast activation protein inhibitor positron emission tomography in inflammatory and infectious diseases: an updated systematic review","volume":"17","author":"Albano","year":"2024","journal-title":"Pharm (Basel)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1825190\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:48Z","timestamp":1776658428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1825190\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":25,"alternative-id":["10.3389\/fonc.2026.1825190"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1825190","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1825190"}}